Immunotherapy is a revolutionary treatment approach that uses the body’s immune system to fight cancer. Unlike traditional cancer treatments, such as chemotherapy and radiation, which aim to destroy cancer cells directly, immunotherapy works by stimulating the immune system to recognize and attack cancer cells.
One of the most widely known types of immunotherapy is checkpoint inhibitors, which block the proteins that prevent immune cells from attacking cancer cells. Drugs like pembrolizumab (Keytruda) and nivolumab (Opdivo) have shown remarkable success in treating various cancers, including melanoma, lung cancer, and head and neck cancer.
Another promising approach is CAR T-cell therapy, which involves modifying a patient’s own T-cells (a type of immune cell) to better recognize and attack cancer cells. CAR T-cell therapy has achieved impressive results in treating certain types of blood cancers, such as leukemia and lymphoma.
Immunotherapy has the potential to offer long-lasting remissions and even cures for certain cancers, with fewer side effects than traditional treatments. Ongoing research is focused on expanding the use of immunotherapy to treat a broader range of cancers.
No comments:
Post a Comment